Some units from the Surgical Hospital are moving to Meilahti: Emergency Clinic for Ear, Nose, and Throat Diseases will become a part of Meilahti Emergency Department
28.1.2025 08:00:00 EET | HUS | Press release
The ear, nose, and throat diseases emergency clinic, urgent care during office hours, ward, and tumor outpatient clinic are moving from the Surgical Hospital to the Meilahti hospital campus. The units begin operating in the new location on February 4, 2025.

Emergency Clinic for Ear, Nose, and Throat Diseases will transfer to Meilahti Emergency Department
The Emergency Clinic for Ear, Nose, and Throat Diseases will become a part of the Meilahti Emergency Department. Access to Meilahti Emergency Department is via the Paciuksenkatu entrance to Bridge Hospital (Paciuksenkatu 3). In future, patients under the age of 16 in need of urgent care are treated at the emergency department of New Children's Hospital. Operation starts in the new premises on Tuesday, February 4, 2025, at 8 a.m.
An emergency referral from a doctor is required for treatment at the unit. If the patient does not have a referral or a previous treatment relationship with ear, nose, and throat diseases, we recommend calling the Medical Helpline at 116117. In an emergency, always call 112.
Units moving to Haartman Hospital
The ear, nose, and throat diseases units moving to the entrance floor of Haartman Hospital are the outpatient clinic that treats tumor patients, and the unit providing urgent care during office hours, where patients arrive with an emergency referral from Meilahti Emergency Department or by separate arrangement.
Haartman Hospital is located at the address Haartmaninkatu 4, in building number 12.
Units moving to Meilahti Bridge Hospital
The Ear, Nose and Throat Diseases Ward K6 will merge with the Oral and Maxillofacial Surgery Ward S7A on the 5th floor of Meilahti Bridge Hospital. The ward’s new name is Head and Neck Surgery Ward S5B. Oral and maxillofacial surgery begins operating in the new premises on Monday, February 3, 2025. The ward's other activities begin on Tuesday, February 4, 2025.
Meilahti Bridge Hospital is located at the address Haartmaninkatu 4, in building number 4. Access to the hospital is via the main entrance to the Meilahti Hospitals.
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m., Fri and eves of public holidays 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
- FIN: Kirurgisen sairaalan toimintoja muuttaa Meilahteen – Korva-, nenä- ja kurkkutautien päivystys siirtyy osaksi Meilahden yhteispäivystystä
- SWE: Delar av verksamheten vid Kirurgiska sjukhusets flyttar till Mejlans – Jouren för öron-, näs- och halssjukdomar flyttar och blir en del av Mejlans samjour
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Lovande resultat vid betainbehandling av den sällsynta sjukdomen AGU20.11.2026 08:01:27 EET | Pressmeddelande
En studie ger nytt hopp till barn som lider av den sällsynta sjukdomen aspartylglukosaminuri (AGU) och deras familjer. Studien visar att intag av betain avsevärt kan förbättra ämnesomsättningen hos barn med AGU samt främja deras kognitiva och fysiska prestationsförmåga.
Betaiinihoidosta lupaavia tuloksia harvinaista AGU-tautia sairastaville20.11.2026 08:01:27 EET | Tiedote
Tutkimus tuo uutta toivoa harvinaista aspartylglukosaminuriaa (AGU) sairastaville lapsille ja heidän perheilleen. Tutkimus osoittaa, että betaiinin käyttö voi parantaa merkittävästi AGU:a sairastavien lasten aineenvaihduntatasoja sekä edistää heidän kognitiivista ja fyysistä suoriutumistaan.
Promising results from betaine in treatment of the rare AGU disease20.11.2026 08:01:27 EET | Press release
A study brings hope to children living with aspartylglucosaminuria (AGU) and their families. The study shows that betaine can significantly improve metabolism in children with AGU and promote their cognitive and physical performance.
Fynd i sköljvätska från munnen kan bidra till en bättre förståelse av långtidscovid19.11.2026 10:44:44 EET | Pressmeddelande
I en studie genomförd av HUS och Helsingfors universitet upptäcktes fler inflammationsmarkörer i vatten som patienter med långtidscovid hade sköljt munnen med än hos kontrollgruppen. Observationen kan bidra till en bättre förståelse av vad som händer i kroppen under en långvarig coronasjukdom.
Suun huuhtelunesteen löydökset voivat auttaa ymmärtämään long covidia paremmin19.11.2026 10:44:44 EET | Tiedote
HUSin ja Helsingin yliopiston tutkimuksessa long covid -potilaiden suun huuhtelunesteestä löytyi enemmän tulehdukseen liittyviä merkkiaineita kuin vertailuryhmältä. Havainto voi auttaa ymmärtämään tarkemmin, mitä elimistössä tapahtuu pitkittyneen koronataudin aikana.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom